ADVERSE REACTIONS WITH 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA, ECSTASY)

Citation
Ud. Mccann et al., ADVERSE REACTIONS WITH 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA, ECSTASY), Drug safety, 15(2), 1996, pp. 107-115
Citations number
88
Categorie Soggetti
Toxicology,"Pharmacology & Pharmacy","Public, Environmental & Occupation Heath
Journal title
ISSN journal
01145916
Volume
15
Issue
2
Year of publication
1996
Pages
107 - 115
Database
ISI
SICI code
0114-5916(1996)15:2<107:ARW3(E>2.0.ZU;2-T
Abstract
3,4-Methylenedioxymethamphetamine (MDMA;'ecstasy') is an increasingly popular recreational drug in the US, Western Europe and Australia. In animals, including nonhuman primates, MDMA is known to damage brain se rotonin (5-hydroxytryptamine; 5-HT) neurons. It is not known whether M DMA damages serotonin neurons in the human brain but there is some ind ication that it may. Although the large majority of individuals who ha ve used MDMA recreationally do not develop acute complications, as the popularity of MDMA has increased, so have reports of adverse nonpsych iatric and psychiatric consequences associated with use of the drug. F urther, since manifestations of MDMA-induced serotonin injury might on ly become apparent with age, or under periods of stress, it is possibl e that some individuals with no apparent abnormalities might develop c omplications over time.